Atlas Trials

Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy

Clinical trial NCT00990587 · COMPLETED

Trial details

NCT number
NCT00990587
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hematologic MalignancyAcute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaMyelodysplasiaAcute Myeloid LeukemiaChronic Myelogenous LeukemiaHodgkin's Disease
Start date
2009-10-01
Primary completion
2013-05-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.